Canadian Pharmaceutical Manufacturers and Exporters Alliance
7 meetings with public office holders, Nov 26, 2025 to Mar 5, 2026.
Meetings over time
- Nov 2025: 3 meetings, with Greg Orencsak, Pamela Aung-Thin, Daniel MacDonald, Philip Jennings, Ritu Banerjee
- Dec 2025: 1 meeting, with Pamela Aung-Thin, David Lee
- Jan 2026: 0 meetings
- Feb 2026: 2 meetings, with Rodrigo Arancibia, Helena Jaczek, Jacques Ramsay, Madeleine Chenette, Doug Eyolfson
- Mar 2026: 1 meeting, with Loris Mirella, Arianne Reza, Joelle Paquette, Gabrielle Dolgoy
Nov 2025peak 3 in a monthMar 2026
Hover or focus a month to see who was met.
What they lobby about
The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.
Who they met
Liberal6 met · 6 meetings
Not in Arena's member list16 met · 19 meetings
- Pamela Aung-Thin
- Ritu Banerjee
- Rodrigo Arancibia
- Arianne Reza
- Daniel MacDonald
- David Lee
- Gabrielle Dolgoy
- Greg Orencsak
- Guillaume Couillard
- Jocelyne Voisin
- Joelle Paquette
- Loris Mirella
- Manuela Tomic
- Paul Moen
- Philip Jennings
- Shalene Curtis-Micallef
Health Canada (HC) (8) · Innovation, Science and Economic Development Canada (ISED) (7) · House of Commons (5) · Public Services and Procurement Canada (PSPC) (2) · Global Affairs Canada (GAC) (2) · Patented Medicine Prices Review Board (PMPRB) (1)
In their own words
- Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations
- Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
- Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.